Humana Inc. (NYSE:HUM) Shares Sold by Financial Partners Group LLC

Financial Partners Group LLC cut its holdings in Humana Inc. (NYSE:HUM) by 84.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,876 shares of the insurance provider’s stock after selling 15,715 shares during the quarter. Financial Partners Group LLC’s holdings in Humana were worth $730,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the business. Secure Asset Management LLC purchased a new stake in shares of Humana during the fourth quarter worth about $244,000. Avior Wealth Management LLC boosted its position in Humana by 19.6% during the fourth quarter. Avior Wealth Management LLC now owns 335 shares of the insurance provider’s stock worth $85,000 after acquiring an additional 55 shares during the last quarter. Crossmark Global Holdings Inc. grew its stake in Humana by 11.2% in the 4th quarter. Crossmark Global Holdings Inc. now owns 9,068 shares of the insurance provider’s stock worth $2,300,000 after acquiring an additional 915 shares during the period. Atwood & Palmer Inc. raised its holdings in Humana by 64.5% in the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock valued at $39,000 after acquiring an additional 60 shares during the last quarter. Finally, Willner & Heller LLC lifted its stake in shares of Humana by 28.2% during the 4th quarter. Willner & Heller LLC now owns 2,002 shares of the insurance provider’s stock worth $508,000 after purchasing an additional 440 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HUM has been the topic of a number of research analyst reports. Cantor Fitzgerald restated a “neutral” rating and issued a $395.00 price target on shares of Humana in a report on Tuesday, October 1st. Royal Bank of Canada lowered their target price on shares of Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a report on Tuesday, October 8th. Jefferies Financial Group downgraded shares of Humana from a “buy” rating to a “hold” rating and cut their price target for the stock from $519.00 to $253.00 in a research note on Monday, October 7th. Leerink Partnrs cut shares of Humana from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, Sanford C. Bernstein raised Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price on the stock in a research report on Tuesday, October 8th. Twenty analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $302.80.

Insiders Place Their Bets

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.32% of the stock is currently owned by corporate insiders.

Humana Price Performance

Shares of NYSE HUM opened at $293.22 on Friday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $35.31 billion, a price-to-earnings ratio of 25.97, a price-to-earnings-growth ratio of 2.15 and a beta of 0.55. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $411.80. The business has a 50 day simple moving average of $273.81 and a 200-day simple moving average of $305.88.

Humana (NYSE:HUM) last released its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating the consensus estimate of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The firm had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. As a group, equities research analysts expect that Humana Inc. will post 16.11 earnings per share for the current year.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.